#Neurodegenerative_Diseases
LightNews LightNews
newsen.bsky.social
Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments#USA#Somerville#Brenig_Therapeutics#Neurodegenerative_Diseases#Megan_McGill
Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments
Brenig Therapeutics announces the appointment of Dr. Megan McGill as CEO, focusing on advancements in therapies for neurodegenerative diseases driven by innovative discovery platforms.
third-news.com
October 30, 2025 at 12:28 PM
shababhannan.bsky.social
Paper alert. We highlight some recent papers published in our special research edition on mitochondria and neuro-developmental+degenerative diseases at Frontiers. #Mitochondria #Neurodegenerative_diseases #Frontiers_in_Neuroscience
www.frontiersin.org/articles/10....
Frontiers | Editorial: Molecular and cellular pathways leading to mitochondrial dysfunction and neurodegeneration: lessons from in vivo models, volume II
The second volume of our editorial is a continuation of the first (Hannan et al., 2022) and features two reviews and three research articles that highlight h...
www.frontiersin.org
January 30, 2025 at 5:37 PM
newsen.bsky.social
Thryv Therapeutics Expands Drug Development with New SGK1 Inhibitors from Spain#Canada#Montreal#Neurodegenerative_Diseases#Thryv_Therapeutics#SGK1_inhibitors
Thryv Therapeutics Expands Drug Development with New SGK1 Inhibitors from Spain
Thryv Therapeutics announces a license from Spain's CSIC and UAM for new SGK1 inhibitors, targeting neurodegenerative diseases like Parkinson's and Alzheimer's.
third-news.com
September 3, 2026 at 8:33 PM
newsen.bsky.social
AD/PD™ 2027 Conference Calls for Research Abstracts on Neurodegenerative Diseases#Spain#Barcelona#Neurodegenerative_Diseases#Alzheimer's_Research#ADPD_Conference
AD/PD™ 2027 Conference Calls for Research Abstracts on Neurodegenerative Diseases
The AD/PD™ 2027 conference invites global researchers to submit abstracts on Alzheimer's and Parkinson's diseases by September 1, 2026, in Barcelona.
third-news.com
August 5, 2026 at 12:39 PM
newsen.bsky.social
BRAINBox Solutions Expands Patent Portfolio for Concussion Diagnostics and Neurodegenerative Disease Testing#United_States#Richmond#Neurodegenerative_Diseases#BRAINBox_Solutions#concussion_diagnostics
BRAINBox Solutions Expands Patent Portfolio for Concussion Diagnostics and Neurodegenerative Disease Testing
BRAINBox Solutions announces the growth of its patent portfolio that enhances technology for diagnosing concussions and neurodegenerative diseases.
third-news.com
April 16, 2026 at 12:39 PM
newsen.bsky.social
Advancements in Tau Research: Rainwater Charitable Foundation Announces 2026 Prize Winners#United_States#Fort_Worth#Neurodegenerative_Diseases#Rainwater_Foundation#Tau_Research
Advancements in Tau Research: Rainwater Charitable Foundation Announces 2026 Prize Winners
The Rainwater Charitable Foundation has recognized groundbreaking research in neurodegenerative diseases with its 2026 Rainwater Prizes, honoring top scientists in the field.
third-news.com
February 5, 2026 at 1:26 PM
newsen.bsky.social
CEO of Klotho Neurosciences to Attend Inaugural Conference in California#USA#Irvine#Neurodegenerative_Diseases#Klotho_Neurosciences#Joseph_Sinkule
CEO of Klotho Neurosciences to Attend Inaugural Conference in California
Klotho Neurosciences announces its CEO will meet investors at the inaugural conference discussing therapies for neurodegenerative diseases.
third-news.com
September 9, 2025 at 4:35 AM
newsen.bsky.social
New Study Reveals Behavioral Insights on Medication Prescribing Choices in Neurodegenerative Diseases#United_Kingdom#Neurodegenerative_Diseases#Medications#Alpharmaxim#Altrincham
New Study Reveals Behavioral Insights on Medication Prescribing Choices in Neurodegenerative Diseases
A pioneering study by Alpharmaxim reveals key insights into how behavior influences medication choices for neurodegenerative disorders, emphasizing the need for optimized strategies.
third-news.com
July 3, 2025 at 7:13 AM
newsen.bsky.social
Comprehensive Insights Into Multiple System Atrophy Therapy Advancements Expected by 2034#USA#Las_Vegas#DelveInsight#Neurodegenerative_Diseases#Multiple_System_Atrophy
Comprehensive Insights Into Multiple System Atrophy Therapy Advancements Expected by 2034
The market for multiple system atrophy is on the rise, promising new therapies to meet unmet needs and improving patient outcomes by 2034.
third-news.com
February 17, 2025 at 10:42 PM
newsen.bsky.social
Mission Therapeutics Reveals New Insights on Mitophagy for Neurodegenerative Disease Treatment#Cambridge#United_Kingdom#Neurodegenerative_Diseases#Mission_Therapeutics#mitophagy
Mission Therapeutics Reveals New Insights on Mitophagy for Neurodegenerative Disease Treatment
Mission Therapeutics' latest publication in Nature Reviews discusses enhancing mitophagy as a promising strategy against neurodegenerative diseases.
third-news.com
January 15, 2025 at 8:38 AM
newsen.bsky.social
Arkuda Therapeutics Secures Johnson & Johnson Partnership for Neuronal Health Innovations#USA#Johnson_&_Johnson#Watertown#Neurodegenerative_Diseases#Arkuda_Therapeutics
Arkuda Therapeutics Secures Johnson & Johnson Partnership for Neuronal Health Innovations
Arkuda Therapeutics has secured a major deal with Johnson & Johnson to advance lysosomal function enhancers for neurodegenerative diseases, signaling hope for Alzheimer's and Parkinson's treatment improvements.
third-news.com
January 9, 2025 at 12:31 PM
newsen.bsky.social
CND Life Sciences Reveals Groundbreaking Test for Neurodegenerative Disease Diagnosis#USA#Scottsdale#Neurodegenerative_Diseases#CND_Life_Sciences#Syn-One_Test
CND Life Sciences Reveals Groundbreaking Test for Neurodegenerative Disease Diagnosis
CND Life Sciences published a study demonstrating the Syn-One Test's effectiveness in diagnosing neurodegenerative diseases accurately.
third-news.com
December 18, 2024 at 4:03 PM
newsen.bsky.social
Exploring the Surge of Pelvic Floor Stimulation Devices: Market Insights and Future Trends#United_States#Las_Vegas#Medtronic#Pelvic_Floor_Devices#Neurodegenerative_Diseases
Exploring the Surge of Pelvic Floor Stimulation Devices: Market Insights and Future Trends
The pelvic floor stimulation devices market is projected to grow at an impressive rate, driven by increasing urinary incontinence and innovative products.
third-news.com
December 5, 2024 at 10:44 PM